NMPA Approval

Gemcitabine Hydrochloride for Injection

Approval Number

国药准字H20233419

Company健进制药有限公司

Registration Date

April 4, 2023

Drug Information

Generic Name

注射用盐酸吉西他滨

Dosage Form

注射剂

Strength

0.2g(按C₉H₁₁F₂N₃O₄计)

Drug Type

化学药品

Registration Date

April 4, 2023

Company Information

Applicant Company

Company Name健进制药有限公司

Company Address

四川省成都高新区西部园区科新路8号附9号

Manufacturing Company

Company Name健进制药有限公司

Company Address

成都高新综合保税区科新路8号附9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸吉西他滨 - NMPA 批准文号 | MedPath